Definium Therapeutics issues inducement options for 115,600 shares to six new hires

Definium Therapeutics issued inducement stock options covering 115,600 common shares to six newly hired non-executive employees.

• The grants carry an Aug. 3, 2026 effective date, with the exercise price set at the closing share price on the grant date.
• The options vest over four years: 25% on the first anniversary, then the remainder in equal monthly installments over the following three years.
• The awards were made under the company’s 2026 Inducement Plan.